Drug Information

Drug General Information
Drug ID
D0FU5E
Former ID
DNC004665
Drug Name
S-34324
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527481]
Formula
C13H15FN2
Canonical SMILES
C1C(CC2=C1C=CC(=C2)F)CC3CN=CN3
InChI
1S/C13H15FN2/c14-12-2-1-10-3-9(4-11(10)6-12)5-13-7-15-8-16-13/h1-2,6,8-9,13H,3-5,7H2,(H,15,16)
InChIKey
HBMJQYDGBNSZMC-UHFFFAOYSA-N
PubChem Compound ID
10220053
Target and Pathway
Target(s) Alpha-2A adrenergic receptor Target Info Inhibitor [527481]
Sodium-dependent noradrenaline transporter Target Info Inhibitor [527481]
Alpha-2C adrenergic receptor Target Info Inhibitor [527481]
Sodium-dependent serotonin transporter Target Info Inhibitor [527481]
Alpha-2B adrenergic receptor Target Info Inhibitor [527481]
KEGG Pathway cGMP-PKG signaling pathway
Neuroactive ligand-receptor interactionhsa04022:cGMP-PKG signaling pathway
Neuroactive ligand-receptor interactionhsa04726:Serotonergic synapsehsa04022:cGMP-PKG signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Alpha adrenergic receptor signaling pathwayP00001:Adrenaline and noradrenaline biosynthesisP00002:Alpha adrenergic receptor signaling pathway
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP04373:5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Reactome Adrenoceptors
Adrenaline signalling through Alpha-2 adrenergic receptor
Adrenaline,noradrenaline inhibits insulin secretion
G alpha (i) signalling events
G alpha (z) signalling events
Surfactant metabolismR-HSA-442660:Na+/Cl- dependent neurotransmitter transportersR-HSA-390696:Adrenoceptors
Surfactant metabolismR-HSA-390696:Adrenoceptors
WikiPathways Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Platelet Aggregation (Plug Formation)
Integration of energy metabolism
GPCR ligand binding
GPCR downstream signalingWP727:Monoamine Transport
NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP58:Monoamine GPCRs
SIDS Susceptibility Pathways
Synaptic Vesicle Pathway
Serotonin Transporter ActivityWP58:Monoamine GPCRs
GPCR downstream signaling
References
Ref 527481J Med Chem. 2005 Mar 24;48(6):2054-71.Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.
Ref 527481J Med Chem. 2005 Mar 24;48(6):2054-71.Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.